With the purpose of enhancing the health of the community, Sanofi has accompanied VCF to sponsor 800 doses of influenza vaccines and heart disease screening for individuals living in remote areas, ...

While the inquiry gets most things right, as vaccine experts, we argue the government response should be broadened in three ...

while VaxigripTetra is manufactured by Sanofi and locally distributed by Sanofi Aventis. Two other influenza vaccines that have been brought into Singapore for the Northern Hemisphere 2020/21 ...

Sanofi SNY reported third ... Dupixent and new product launches. Vaccine sales rose 25.5% to €3.8 billion, driven by earlier-than-anticipated deliveries of respiratory syncytial virus (RSV), vaccine ...

Now that the U.S. Food and Drug Administration has approved the at-home use of the flu vaccine spray FluMist, how do you know that it's the right choice for you and your family? One expert offers ...

As usual, you can find the slides on sanofi.com ... in the quarter. Our Vaccine business grew 26%. This increase benefited ...

Vaccine sales also improved in the quarter, boosted by early delivery of flu sales and by Beyfortus due to approved production capacity. Sanofi’s shares rose 2.8% in pre-market trading on Friday ...

Sanofi profit rose on demand for seasonal vaccines and further growth in its blockbuster skin and asthma therapy Dupixent. Earnings per share excluding some items reached 2.86 euros (S$4.08) in the ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine ... phasing of flu and ...

boosted by earlier-than-anticipated deliveries of flu and respiratory syncytial virus vaccines and growing demand for blockbuster anti-inflammatory drug Dupixent. Sanofi’s third-quarter results ...